107 related articles for article (PubMed ID: 1469781)
1. [Evaluation of hypercoagulable state in patients with malignancies by using prothrombin fragment F1 + 2].
Nakagawa K; Tsuji H; Yamada K; Yamada Y; Masuda H; Yamagami M; Yoneda M; Takada O; Sawada S; Kitani T
Rinsho Ketsueki; 1992 Nov; 33(11):1666-72. PubMed ID: 1469781
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
[TBL] [Abstract][Full Text] [Related]
3. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
[TBL] [Abstract][Full Text] [Related]
5. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
6. Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
Ingerslev J; Holm M; Christiansen K; Knudsen L; Négrier C
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S129-34. PubMed ID: 9819044
[TBL] [Abstract][Full Text] [Related]
7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
8. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
[TBL] [Abstract][Full Text] [Related]
9. Elevated prothrombin fragment 1 + 2 (F1 + 2) plasma levels may provide evidence of hypercoagulable states in gynecologic emergencies.
Anand A
Gynecol Oncol; 1994 Jul; 54(1):101. PubMed ID: 8020831
[No Abstract] [Full Text] [Related]
10. Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancer.
Gadducci A; Marrai R; Baicchi U; Gagetti O; Facchini V; Genazzani AR
Gynecol Oncol; 1996 May; 61(2):215-7. PubMed ID: 8626135
[TBL] [Abstract][Full Text] [Related]
11. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
15. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
16. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
17. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
18. [Clinical application of laboratory diagnosis: leukemia and DIC].
Deguchi K; Zhao LJ; Shirakawa S
Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
[TBL] [Abstract][Full Text] [Related]
19. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]